rindopepimut: Clinical Trials

4 completed, 1 no longer available, 1 terminated. 2 Phase 1, 2 Phase 2, 1 Phase 3.

By phase and status

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Bevacizumab, Rindopepimut (CDX-110) with GM-CSF, KLH - Glioblastoma, Small Cell Glioblastoma	Phase 2	Completed	Celldex Therapeutics	127	2011-12-01	2020-02-17
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma Rindopepimut (CDX-110) with GM-CSF, Temozolomide, KLH - Glioblastoma, Small Cell Glioblastoma	Phase 3	Completed	Celldex Therapeutics	745	2011-11-01	2018-01-16
Phase I Rindopepimut After Conventional Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas Rindopepimut - Brain Cancer, Brain Stem Tumors	Phase 1	Terminated	Paul Graham Fisher	3	2011-06-01	2021-09-27
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme CDX-110 with GM-CSF, Temozolomide - Malignant Glioma	Phase 2	Completed	Celldex Therapeutics	82	2007-08-01	2018-01-16
Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery PEP-3-KLH conjugate vaccine, daclizumab, temozolomide - Malignant Neoplasms of Brain	Phase 1	Completed	John Sampson	16	2007-03-01	2016-01-21
Expanded Access (Compassionate Use) Treatment Protocol Rindopepimut rindopepimut - Recurrent GBM		No longer available	Celldex Therapeutics			2017-10-18